Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …
Advances in aptamer-mediated targeted delivery system for cancer treatment
S He, Y Du, H Tao, H Duan - International Journal of Biological …, 2023 - Elsevier
Aptamers with high affinity and specificity for certain targets have rapidly become a novel
class of targeted ligands applicated in drug delivery. Based on the excellent characteristics …
class of targeted ligands applicated in drug delivery. Based on the excellent characteristics …
[HTML][HTML] Biomedical applications of aptamer-modified chitosan nanomaterials: An updated review
S Fathi-Karkan, S Mirinejad, F Ulucan-Karnak… - International Journal of …, 2023 - Elsevier
Among polysaccharides of environmental and economic interest, chitosan (CS) is receiving
much attention, particularly in the food and biotechnology industries to encapsulate active …
much attention, particularly in the food and biotechnology industries to encapsulate active …
Functionalized chitosan for cancer nano drug delivery
Chitosan is a biotechnological derivative of chitin receiving a widespread pharmaceutical
and biomedical applications. It can be used to encapsulate and deliver cancer therapeutics …
and biomedical applications. It can be used to encapsulate and deliver cancer therapeutics …
pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment
A Sathiyaseelan, K Saravanakumar… - Carbohydrate …, 2021 - Elsevier
This study developed the pH, and over-expressed nucleolin receptor responsive nano-drug
delivery system (nDDS) composed by bio-synthesized gold nanoparticles (Au NPs) …
delivery system (nDDS) composed by bio-synthesized gold nanoparticles (Au NPs) …
Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics
There is a surge in demand for safe and targeted therapy against cancer as the conventional
treatment approach fails to reach the specific site. Chemotherapeutic agents are generally …
treatment approach fails to reach the specific site. Chemotherapeutic agents are generally …
Engineered Magnetic Polymer Nanoparticles Can Ameliorate Breast Cancer Treatment Inducing Pyroptosis–Starvation along with Chemotherapy
Y Liu, K Guo, M Ding, B Zhang, N **ao… - … Applied Materials & …, 2022 - ACS Publications
Nanotechnology has shown a revolution in cancer treatments, including breast cancers.
However, there remain some challenges and translational hurdles. Surgery, radiotherapy …
However, there remain some challenges and translational hurdles. Surgery, radiotherapy …
Recent advances in chitosan and its derivatives in cancer treatment
J Ding, Y Guo - Frontiers in Pharmacology, 2022 - frontiersin.org
Cancer has become a main public health issue globally. The conventional treatment
measures for cancer include surgery, radiotherapy and chemotherapy. Among the various …
measures for cancer include surgery, radiotherapy and chemotherapy. Among the various …
Chitosan-based nanosystems for cancer diagnosis and therapy: Stimuli-responsive, immune response, and clinical studies
Cancer, a global health challenge of utmost severity, necessitates innovative approaches
beyond conventional treatments (eg, surgery, chemotherapy, and radiation therapy) …
beyond conventional treatments (eg, surgery, chemotherapy, and radiation therapy) …
Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer
Lung cancer (LC), related with the enhanced expression of epidermal growth factor receptor
(EGFR) and sialic acid binding receptors (glycan) brought about the development of EGFR …
(EGFR) and sialic acid binding receptors (glycan) brought about the development of EGFR …